ACYCLOVIR

Acyclovir Adverse Events Reported to the FDA Over Time

How are Acyclovir adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Acyclovir, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Acyclovir is flagged as the suspect drug causing the adverse event.

Most Common Acyclovir Adverse Events Reported to the FDA

What are the most common Acyclovir adverse events reported to the FDA?

Renal Failure Acute	204 (1.9%)
Drug Ineffective	167 (1.55%)
Pyrexia	131 (1.22%)
Vomiting	105 (.98%)
Confusional State	98 (.91%)
Rash	97 (.9%)
Herpes Zoster	96 (.89%)
Blood Creatinine Increased	93 (.87%)
Hepatotoxicity	89 (.83%)
Nausea	89 (.83%)
Diarrhoea	84 (.78%)
	Show More
Neutropenia	84 (.78%)
Neurotoxicity	82 (.76%)
Renal Failure	72 (.67%)
Renal Impairment	71 (.66%)
Malaise	70 (.65%)
Death	67 (.62%)
Drug Interaction	61 (.57%)
Dyspnoea	60 (.56%)
Fatigue	59 (.55%)
Somnolence	57 (.53%)
Convulsion	55 (.51%)
Dilatation Intrahepatic Duct Acquir...	55 (.51%)
Blood Bilirubin Increased	54 (.5%)
Dizziness	54 (.5%)
Liver Function Test Abnormal	54 (.5%)
Alanine Aminotransferase Increased	53 (.49%)
Dysarthria	53 (.49%)
Hallucination	52 (.48%)
Headache	52 (.48%)
Hypotension	49 (.46%)
Pruritus	49 (.46%)
Sepsis	49 (.46%)
Abdominal Pain	48 (.45%)
Agitation	48 (.45%)
Oedema	48 (.45%)
Anaemia	47 (.44%)
Aphasia	47 (.44%)
Encephalopathy	46 (.43%)
Febrile Neutropenia	46 (.43%)
Hallucination, Visual	46 (.43%)
Arthralgia	45 (.42%)
Nephropathy Toxic	44 (.41%)
Thrombocytopenia	44 (.41%)
Mental Status Changes	43 (.4%)
Blood Urea Increased	41 (.38%)
Drug Exposure During Pregnancy	41 (.38%)
Haemodialysis	41 (.38%)
Rash Maculo-papular	41 (.38%)
Erythema	40 (.37%)
Pneumonia	39 (.36%)
Respiratory Failure	39 (.36%)
Blood Alkaline Phosphatase Increase...	38 (.35%)
Cytomegalovirus Infection	38 (.35%)
Dehydration	38 (.35%)
Pain	38 (.35%)
Asthenia	37 (.34%)
Ataxia	37 (.34%)
Condition Aggravated	37 (.34%)
Gait Disturbance	37 (.34%)
Overdose	37 (.34%)
Venoocclusive Liver Disease	37 (.34%)
Encephalitis Herpes	36 (.34%)
Haemoglobin Decreased	36 (.34%)
Drug Toxicity	35 (.33%)
Coma	34 (.32%)
Angioedema	33 (.31%)
Disorientation	32 (.3%)
Drug Hypersensitivity	32 (.3%)
Encephalitis	30 (.28%)
Pain In Extremity	30 (.28%)
Aspartate Aminotransferase Increase...	29 (.27%)
Multi-organ Failure	29 (.27%)
Toxic Epidermal Necrolysis	29 (.27%)
Coordination Abnormal	28 (.26%)
Drug Resistance	28 (.26%)
Leukopenia	28 (.26%)
Psychotic Disorder	28 (.26%)
Graft Versus Host Disease	27 (.25%)
Herpes Simplex	27 (.25%)
Muscular Weakness	27 (.25%)
Rash Erythematous	27 (.25%)
Stevens-johnson Syndrome	27 (.25%)
Vision Blurred	27 (.25%)
Abdominal Distension	26 (.24%)
Altered State Of Consciousness	26 (.24%)
Back Pain	26 (.24%)
Herpes Virus Infection	26 (.24%)
Hypertension	26 (.24%)
Palmar-plantar Erythrodysaesthesia ...	26 (.24%)
Skin Toxicity	26 (.24%)
Tremor	26 (.24%)
Loss Of Consciousness	25 (.23%)
Nervous System Disorder	25 (.23%)
Alopecia	24 (.22%)
Bradycardia	24 (.22%)
Hyponatraemia	24 (.22%)
Myalgia	24 (.22%)
Paraesthesia	24 (.22%)
Platelet Count Decreased	24 (.22%)
Sinoatrial Block	24 (.22%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Acyclovir, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Acyclovir is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Acyclovir

What are the most common Acyclovir adverse events reported to the FDA?

Neurological	788 (7.34%)
Epidermal And Dermal Conditions	632 (5.88%)
Renal Disorders	423 (3.94%)
Viral Infectious	414 (3.85%)
Infections - Pathogen Unspecified	322 (3%)
Gastrointestinal Signs	314 (2.92%)
Therapeutic And Nontherapeutic Effe...	314 (2.92%)
Hepatic And Hepatobiliary	276 (2.57%)
Hepatobiliary	269 (2.5%)
Hematology Investigations	243 (2.26%)
Cardiac Arrhythmias	224 (2.09%)
	Show More
Respiratory	211 (1.96%)
White Blood Cell	194 (1.81%)
Renal And Urinary Tract Investigati...	178 (1.66%)
Disturbances In Thinking	152 (1.42%)
Deliria	149 (1.39%)
Muscle	137 (1.28%)
Body Temperature Conditions	135 (1.26%)
Gastrointestinal Motility And Defec...	127 (1.18%)
Movement Disorders	121 (1.13%)
Seizures	116 (1.08%)
Medication Errors	104 (.97%)
Bacterial Infectious	101 (.94%)
Electrolyte And Fluid Balance Condi...	100 (.93%)
Chemical Injury And Poisoning	96 (.89%)
Anemias Nonhemolytic And Marrow Dep...	95 (.88%)
Anxiety Disorders	87 (.81%)
Immune	85 (.79%)
Lower Respiratory Tract Disorders	83 (.77%)
Encephalopathies	78 (.73%)
Joint	77 (.72%)
Musculoskeletal And Connective Tiss...	77 (.72%)
Nephropathies	73 (.68%)
Decreased And Nonspecific Blood Pre...	72 (.67%)
Fatal Outcomes	68 (.63%)
Hematological And Lymphoid Tissue T...	68 (.63%)
Ocular Infections, Irritations And ...	68 (.63%)
Cardiac And Vascular Investigations	67 (.62%)
Oral Soft Tissue Conditions	67 (.62%)
Skin Appendage Conditions	67 (.62%)
Enzyme	66 (.61%)
Allergic Conditions	65 (.61%)
Bile Duct	65 (.61%)
Vision	63 (.59%)
Mental Impairment	62 (.58%)
Fungal Infectious	60 (.56%)
Sleep Disorders	56 (.52%)
Neurological, Special Senses And Ps...	55 (.51%)
Urinary Tract Signs	55 (.51%)
Headaches	53 (.49%)
Angiedema And Urticaria	51 (.47%)
Water, Electrolyte And Mineral	51 (.47%)
Psychiatric	48 (.45%)
Skin And Subcutaneous Tissue	48 (.45%)
Platelet	47 (.44%)
Upper Respiratory Tract Disorders	46 (.43%)
Central Nervous System Vascular	45 (.42%)
Microbiology And Serology	44 (.41%)
Vascular	42 (.39%)
Abortions And Stillbirth	40 (.37%)
Injuries	40 (.37%)
Central Nervous System Infections A...	38 (.35%)
Administration Site Reactions	36 (.34%)
Appetite And General Nutritional	36 (.34%)
Protein And Chemistry Analyses	36 (.34%)
Gastrointestinal Inflammatory Condi...	34 (.32%)
Pregnancy, Labour, Delivery And Pos...	34 (.32%)
Procedural And Device Related Injur...	34 (.32%)
Toxicology And Therapeutic Drug Mon...	34 (.32%)
Metabolic, Nutritional And Blood Ga...	33 (.31%)
Increased Intracranial Pressure And...	31 (.29%)
Gastrointestinal Hemorrhages	30 (.28%)
Mood Disorders	30 (.28%)
Coagulopathies And Bleeding Diathes...	29 (.27%)
Cranial Nerve Disorders	29 (.27%)
Lifestyle Issues	28 (.26%)
Physical Examination Topics	28 (.26%)
Schizophrenia And Other Psychotic	28 (.26%)
Vascular Hypertensive	27 (.25%)
Cardiac And Vascular Disorders Cong...	24 (.22%)
Gastrointestinal Ulceration And Per...	23 (.21%)
Metastases	23 (.21%)
Adrenal Gland	21 (.2%)
Depressed Mood Disorders	21 (.2%)
Skin Vascular Abnormalities	21 (.2%)
Tissue	21 (.2%)
Tongue Conditions	21 (.2%)
Vascular Hemorrhagic	21 (.2%)
Anterior Eye Structural Change, Dep...	20 (.19%)
Bronchial Disorders	20 (.19%)
Eye	20 (.19%)
Eye Disorders Congenital	20 (.19%)
Acid-base	19 (.18%)
Bone Disorders	19 (.18%)
Ocular Neuromuscular	19 (.18%)
Structural Brain	19 (.18%)
Gastrointestinal Tract Disorders Co...	18 (.17%)
Musculoskeletal And Connective Tiss...	18 (.17%)
Maternal Complications Of Pregnancy	17 (.16%)
Synovial And Bursal	17 (.16%)
Vascular Inflammations	17 (.16%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Acyclovir, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Acyclovir is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.